PreDxion Bio's Seed Round

PreDxion Bio raised a round of funding on August 23, 2017. Investors include Y Combinator.

PreDxion Bio develops MicroKine, a diagnostic tool that measures a patient's immune response. It can identify up to six cytokine proteins within 30 minutes from a drop of blood. Using this technology,…

Articles about PreDxion Bio's Seed Round: